GeneDx Holdings (WGS) Other Non-Current Assets (2020 - 2026)
GeneDx Holdings (WGS) reported Other Non-Current Assets of $4.3 million for Q1 2026, up 0.71% year-over-year from $4.3 million in Q1 2025, and down 0.74% quarter-over-quarter from $4.3 million in Q4 2025.
GeneDx Holdings (WGS) Other Non-Current Assets (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has 7 years of Other Non-Current Assets data on file, last reported at $4.3 million in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $4.3 million, up 0.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.3 million (up 0.71% YoY), and the FY2025 annual result was $4.3 million, changed 0.23% from the prior year.
- Other Non-Current Assets declined to $4.3 million in Q1 2026 per WGS's latest filing, from $4.3 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $14.4 million in Q2 2022 and troughed at $900000.0 in Q1 2022.
- A 5-year average of $5.8 million and a median of $4.3 million in 2024 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets jumped 1400.0% in 2022, then slumped 93.74% in 2023.
- A 5-year view of Other Non-Current Assets shows it stood at $7.4 million in 2022, then slumped by 40.24% to $4.4 million in 2023, then fell by 2.42% to $4.3 million in 2024, then gained by 0.23% to $4.3 million in 2025, then declined by 0.74% to $4.3 million in 2026.
- Business Quant data shows WGS's Other Non-Current Assets at $4.3 million in Q1 2026, $4.3 million in Q4 2025, and $4.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 498.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 5.97 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 4.21 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 552.79 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 1.18 Bn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 51.00 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 489.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 523.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 454.16 Mn |
| 10 | GeneDx Holdings | 1.65 Bn | 1.48 Bn | 68.21 Mn | 4.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.28 Mn |
| Dec 31, 2025 | 4.32 Mn |
| Sep 30, 2025 | 4.31 Mn |
| Jun 30, 2025 | 4.31 Mn |
| Mar 31, 2025 | 4.25 Mn |
| Dec 31, 2024 | 4.31 Mn |
| Sep 30, 2024 | 4.34 Mn |
| Jun 30, 2024 | 4.36 Mn |
| Mar 31, 2024 | 4.38 Mn |
| Dec 31, 2023 | 4.41 Mn |
| Sep 30, 2023 | 6.06 Mn |
| Jun 30, 2023 | 900,000.00 |
| Mar 31, 2023 | 13.04 Mn |
| Dec 31, 2022 | 7.39 Mn |
| Sep 30, 2022 | 13.50 Mn |
| Jun 30, 2022 | 14.37 Mn |
| Mar 31, 2022 | 900,000.00 |
| Dec 31, 2021 | 900,000.00 |
| Sep 30, 2021 | 900,000.00 |
| Jun 30, 2021 | 10.83 Mn |